Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19)

PHASE2UnknownINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

March 31, 2023

Study Completion Date

April 30, 2023

Conditions
COVID-19
Interventions
BIOLOGICAL

SARS-CoV-2 Vaccine (Vero Cells), Inactivated

"2 doses of SARS-CoV-2 Vaccine (Vero Cells), Inactivated with a 28-day interval constitute a primary immunization course. The third dose on 6 months after primary course is the booster dose.~Administer as an intramuscular injection into the lateral deltoid of the upper arm."

BIOLOGICAL

Placebo

2 doses of Placebo should be administered as an intramuscular injection into the lateral deltoid of the upper arm with a 28-day interval.

Trial Locations (1)

410005

Hunan Provincial Center for Diseases Control and Prevention, Changsha

Sponsors
All Listed Sponsors
collaborator

Beijing Minhai Biotechnology Co., Ltd

INDUSTRY

collaborator

Hunan Provincial Center for Disease Control and Prevention

OTHER

lead

Shenzhen Kangtai Biological Products Co., LTD

INDUSTRY